Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT06575725
What this trial is testing

Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer

Who this might be right for
Advanced Colon AdenocarcinomaAdvanced Colorectal AdenocarcinomaAdvanced Rectal Adenocarcinoma+9 more
City of Hope Medical Center
Not applicableStudy completedNCT06083974
What this trial is testing

Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy

Who this might be right for
Metastatic Colorectal Adenocarcinoma
Assiut University 100
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00134069
What this trial is testing

Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage III Colon Cancer+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)UnknownNCT00294827
What this trial is testing

Liver Transplantation and Metastatic Colo-rectal Cancer.

Who this might be right for
Colo-rectal Cancer
Oslo University Hospital 25
Testing effectiveness (Phase 2)Study completedNCT00081627
What this trial is testing

Clinical Trial in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Mast Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT00003674
What this trial is testing

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Alliance for Clinical Trials in Oncology 141
Testing effectiveness (Phase 2)Study completedNCT00003220
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00149396
What this trial is testing

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerLiver Neoplasms
MediGene 32
Testing effectiveness (Phase 2)Study completedNCT00111774
What this trial is testing

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

Who this might be right for
Colorectal CancerCarcinoma
Amgen 150
Large-scale testing (Phase 3)Ended earlyNCT00006269
What this trial is testing

Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

Who this might be right for
Colorectal CancerDiarrhea
Novartis 89
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Early research (Phase 1)UnknownNCT00010270
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University Hospital Freiburg 50
Not applicableStudy completedNCT02955173
What this trial is testing

Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer

Who this might be right for
Circulating Tumor CellsColorectal CancerGastric Cancer
Qilu Hospital of Shandong University 467
Testing effectiveness (Phase 2)Study completedNCT00077337
What this trial is testing

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)UnknownNCT01157806
What this trial is testing

Palliative Radiochemotherapy Against Palliative Surgery in Stage IV Rectal Cancer With Unresectable Metastases

Who this might be right for
Rectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 20
Testing effectiveness (Phase 2)UnknownNCT00544011
What this trial is testing

Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hopital Jean Minjoz 47
Testing effectiveness (Phase 2)Study completedNCT01205711
What this trial is testing

Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cardiff University 111
Testing effectiveness (Phase 2)Ended earlyNCT00588900
What this trial is testing

Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 5
Early research (Phase 1)Ended earlyNCT02205398
What this trial is testing

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Who this might be right for
Squamous Cell Carcinoma of Head and Neck (SCCHN)Metastatic Colorectal Cancer
Novartis Pharmaceuticals 13
Next Page